Related Experiment Video

Updated: Aug 18, 2026

Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
10:11

Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System

Published on: January 31, 2018

Hepatitis C and the British Columbia experience with hepatitis A vaccination

P Daly1

  • 1Communicable Disease Control, Vancouver/Richmond Health Board, Canada.

Journal of Viral Hepatitis
|June 28, 2000
PubMed

Insights

Hepatitis C virus (HCV) and hepatitis A virus (HAV) outbreaks often affect the same high-risk groups in British Columbia. Vaccinating these individuals against HAV is crucial to prevent fatal outcomes in those with HCV.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis C virus (HCV) affects approximately 1.5% of the British Columbia population.
  • High-risk populations for HCV are also susceptible to hepatitis A virus (HAV) outbreaks.
  • HAV infection poses a fatal risk to individuals with pre-existing HCV.

Purpose of the Study:

  • To highlight the recognized importance of HAV vaccination in populations at high risk for HCV.
  • To underscore the public health strategies aimed at minimizing HAV spread within vulnerable groups.

Main Methods:

  • Review of provincial experience and epidemiological data regarding HCV and HAV prevalence.
  • Analysis of risk factors common to both viral hepatitis infections.
  • Evaluation of implemented public health strategies for disease prevention.

Main Results:

  • Identification of overlapping high-risk groups for both HCV and HAV infections.
  • Recognition of the critical need for HAV vaccination in HCV-positive individuals.
  • Confirmation that targeted vaccination strategies are essential for this population.

Conclusions:

  • HAV vaccination is a vital preventive measure for individuals at high risk of HCV infection.
  • Public health initiatives must focus on vaccinating vulnerable populations to mitigate severe health consequences.
  • Integrated strategies are necessary to control viral hepatitis transmission in British Columbia.

More Related Videos

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
Vaccinations01:51

Vaccinations

Overview
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...